- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Big Green Snowflakes
Swedish Pharmaceuticals & Biotech Big Green Snowflakes
Results
101
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
101 companies
PExA
Market Cap: SEK 13.4m
Develops and commercializes diagnostic products in various respiratory diseases.
PEXA B
SEK 0.23
7D
-1.7%
1Y
-40.4%
Infant Bacterial Therapeutics
Market Cap: SEK 991.5m
Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.
IBT B
SEK 73.60
7D
-4.0%
1Y
110.3%
Oncopeptides
Market Cap: SEK 1.2b
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 5.10
7D
6.4%
1Y
132.3%
Vivesto
Market Cap: SEK 119.7m
Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 0.22
7D
-4.3%
1Y
-12.4%
IRLAB Therapeutics
Market Cap: SEK 248.4m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 2.93
7D
8.5%
1Y
-78.1%
Enzymatica
Market Cap: SEK 555.9m
A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.
ENZY
SEK 2.29
7D
-3.8%
1Y
-11.9%
Coegin Pharma
Market Cap: SEK 158.7m
A biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden.
COEGIN
SEK 6.38
7D
16.0%
1Y
20.4%
Modus Therapeutics Holding
Market Cap: SEK 134.4m
A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.
MODTX
SEK 1.11
7D
-17.8%
1Y
-39.5%
Chosa Oncology
Market Cap: SEK 34.4m
Develops oncology drugs for the treatment of cancer.
CHOSA
SEK 0.53
7D
0%
1Y
-59.2%
Quia Pharma
Market Cap: SEK 7.5m
Engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform.
QUIA
SEK 0.0038
7D
0%
1Y
-84.4%
Dextech Medical
Market Cap: SEK 132.2m
Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.
DEX
SEK 7.15
7D
-10.6%
1Y
68.6%
Dicot Pharma
Market Cap: SEK 1.7b
Engages in the development of pharmaceutical products in Sweden.
DICOT
SEK 0.87
7D
3.0%
1Y
430.5%
ODI Pharma
Market Cap: SEK 28.6m
A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.
ODI
SEK 1.56
7D
-1.3%
1Y
-68.8%
BICO Group
Market Cap: SEK 1.6b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 22.84
7D
-4.0%
1Y
-57.2%
Enorama Pharma
Market Cap: SEK 200.6m
A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.
ERMA
SEK 2.69
7D
7.6%
1Y
-40.5%
Cessatech
Market Cap: DKK 204.3m
A pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark.
CESSA
DKK 11.00
7D
-0.4%
1Y
-31.3%
Promimic
Market Cap: SEK 348.6m
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
PRO
SEK 18.45
7D
16.8%
1Y
-46.5%
Orexo
Market Cap: SEK 868.5m
A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 25.30
7D
8.4%
1Y
68.7%
LIDDS
Market Cap: SEK 9.5m
A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.
LIDDS
SEK 0.07
7D
22.5%
1Y
-42.3%
Hamlet BioPharma
Market Cap: SEK 746.3m
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
HAMLET B
SEK 4.20
7D
14.3%
1Y
1.4%
Pila Pharma
Market Cap: SEK 87.7m
Operates as a clinical stage biotech company in Sweden.
PILA
SEK 2.09
7D
-12.0%
1Y
-61.4%
SenzaGen
Market Cap: SEK 172.3m
Provides non-animal tests for assessing allergenicity.
SENZA
SEK 5.84
7D
-0.3%
1Y
-23.7%
Lipum
Market Cap: SEK 312.9m
A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.
LIPUM
SEK 14.75
7D
4.6%
1Y
20.9%
Gabather
Market Cap: SEK 8.8m
A pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases.
GABA
SEK 0.037
7D
-6.5%
1Y
-94.2%
Xintela
Market Cap: SEK 272.8m
A biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy.
XINT
SEK 0.39
7D
4.6%
1Y
-26.4%
Magnasense
Market Cap: SEK 11.8m
Develops and commercializes diagnostic tests for monitoring and optimizing the dosage of biological drugs.
MAGNA
SEK 0.0072
7D
12.5%
1Y
-97.5%
PEPTONIC medical
Market Cap: SEK 92.1m
A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.
PMED
SEK 0.06
7D
0%
1Y
-27.7%
Cereno Scientific
Market Cap: SEK 2.6b
A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden and internationally.
CRNO B
SEK 9.09
7D
-3.8%
1Y
55.5%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%